Immunogenicity and Safety of Live Attenuated Influenza Vaccine (Flumist) Administered by Nasal and Sublingual Route

NCT01488188 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Healthy

Interventions

BIOLOGICAL: Influenza vaccine
BIOLOGICAL: Influenza vaccine

Sponsor

International Vaccine Institute